Immune cells in the womb lining and blood of women with fertility problems
Compares immune cells in womb lining and blood of women with infertility or miscarriages.
Key facts
- Who runs it
- Jagiellonian University
- Where
- Poland1 site in 1 countryChoose a country to see its sites
- Trial code
- Registry title
- Immune Cell Populations in the Endometrium
- Status
- Recruiting
- People taking part
- 50 people, planned
- Started
- 1 Jul 2025
- Planned end
- 30 Jun 2026
- Type of study
- Observational, 2 groups
- Treatments tested
- Percentage distribution of immune system cells in peripheral blood
- Percentage distribution of immune system cells in endometrium
- Record updated
- 19 March 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for women with unexplained infertility or at least 2 miscarriages, and fertile women for comparison. It studies immune cells in the blood and the lining of the womb.
- Age
- 18 to 45 years
- Sex
- Women only
- Disease stage
- Unexplained (idiopathic) infertility, at least 2 miscarriages, or other non-cancerous gynecological conditions where a sample of the womb lining is taken. A comparison group of women with a past normal pregnancy conceived naturally.
- Earlier treatment
- No antibiotic treatment within the last 3 months.
Main reasons for not taking part
- Miscarriage within the last 3 months
- Abdominal or womb surgery within the last 3 months
- Viral or bacterial infection within the last 3 months
- Antibiotic treatment within the last 3 months
The registry criteria, word for word
Show all 8 criteriaShow less
Who can take part
- age 18-45 years
- idiopathic infertility
- at least 2 miscarriages
- other benign gynecological conditions subjected to endometrial sampling
Who cannot take part
- abdominal/uterine surgery within last 3 months
- antibiotic therapy within last 3 months
- viral/bacterial infection within last 3 months
- miscarriage within last 3 months
The main criteria, as questions
These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Are you between 18 and 45 years old?
This trial is currently available in Poland.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Specialized immunological studies in the diagnostics of idiopathic infertility and recurrent miscarriages have limited applicability, as the role of the immune system in these conditions is not thoroughly understood. In ovulatory cycles, changes occur in the populations of uterine lymphocytes, which may influence the receptivity of the endometrium and the implantation of the embryo. Particularly notable are the changes in natural killer (NK) cells, which reach their peak during the luteal phase and regulate the invasion of the trophoblast. The dominant NK cells exhibit a CD56bright phenotype and differ in cytokine profiles from peripheral blood cells. Cyclical changes also affect macrophages and T lymphocytes; however, it is unclear whether their proportions differ in women with reduced fertility. There is a need to investigate how the composition of lymphocytes in blood influences the populations in the endometrium. The aim of this study is to analyze the correlation between peripheral and endometrial lymphocytes in women with idiopathic infertility and recurrent miscarriages, compared to fertile women.
The 2 groups in the trial
- Infertility
Women aged 18-45 with idiopathic infertility/recurrent miscarriages
Treatment: Percentage distribution of immune system cells in peripheral blood and Percentage distribution of immune system cells in endometrium
- Normal fertility
Women aged 18-45 with a history of normal pregnancy obtained by spontaneous fertilization
Treatment: Percentage distribution of immune system cells in peripheral blood and Percentage distribution of immune system cells in endometrium
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Analysis of Immune Cell Populations in the Endometrium and Peripheral Blood in Women With Reduced and Normal Fertility
- Plain-language title
- Immune cells in the womb lining and blood of women with fertility problemsGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 15 November 2026.
- Criteria questions
- Built from NCT06826365, who can take part
- Record updated
- 19 March 2026